A Phase I Study of PP-001 Eye Drops in Healthy Adult Volunteers
NCT03769454
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
45
Enrollment
INDUSTRY
Sponsor class
Conditions
Keratoconjunctivitis
Ocular Surface Disease
Interventions
DRUG:
PP-001
OTHER:
Placebo
Sponsor
Panoptes Pharma GmbH